Chicago-based Vistria Group bought into data science and machine learning companies Medalogix and Muse Healthcare to create a medtech company covering a third of all Medicare home health and hospice recipients.
As Congress considers legislation to reform prescription drug pricing, a new analysis conducted by the West Health Policy Center and released by its Council for Informed Drug Spending Analysis (CIDSA) estimates that the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) could result in hundreds of billions of dollars in lower commercial health insurance costs by 2030.